enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Luteinizing hormone - Wikipedia

    en.wikipedia.org/wiki/Luteinizing_hormone

    Luteinizing hormone (LH, also known as luteinising hormone, [1] lutropin and sometimes lutrophin [2]) is a hormone produced by gonadotropic cells in the anterior pituitary gland. The production of LH is regulated by gonadotropin-releasing hormone (GnRH) from the hypothalamus. [ 3 ]

  3. Androgen deprivation therapy - Wikipedia

    en.wikipedia.org/wiki/Androgen_deprivation_therapy

    LHRH activates the synthesis of LH (Luteinizing hormone) within the pituitary gland. LH induces testosterone synthesis within the testicles. [10] There are two different medicines, LHRH agonists and antagonists, which both lower the amount of testosterone made by the testicles. They work by inhibiting the formation of LH in the pituitary gland.

  4. Hyperestrogenism - Wikipedia

    en.wikipedia.org/wiki/Hyperestrogenism

    Signs of hyperestrogenism may include heightened levels of one or more of the estrogen sex hormones (usually estradiol and/or estrone), lowered levels of follicle-stimulating hormone and/or luteinizing hormone (due to suppression of the hypothalamic–pituitary–gonadal axis by estrogen), and lowered levels of androgens such as testosterone (generally only relevant to males). [1]

  5. Hypergonadotropic hypogonadism - Wikipedia

    en.wikipedia.org/wiki/Hypergonadotropic_hypogonadism

    Hypergonadotropic hypogonadism (HH), also known as primary or peripheral/gonadal hypogonadism or primary gonadal failure, is a condition which is characterized by hypogonadism which is due to an impaired response of the gonads to the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and in turn a lack of sex steroid production. [1]

  6. Exemestane - Wikipedia

    en.wikipedia.org/wiki/Exemestane

    Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. [3] US FDA approval was in October 1999. [4]

  7. Gonadotropin-releasing hormone modulator - Wikipedia

    en.wikipedia.org/wiki/Gonadotropin-releasing...

    GnRH modulators affect the secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn affects the gonads, influencing their function and hence fertility as well as the production of sex steroids, including that of estradiol and progesterone in women and of testosterone in men.

  8. Anabolic steroid - Wikipedia

    en.wikipedia.org/wiki/Anabolic_steroid

    In the HPG axis, gonadotropin-releasing hormone (GnRH) is secreted from the arcuate nucleus of the hypothalamus and stimulates the anterior pituitary to secrete the two gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH). [130] In adult males, LH stimulates the Leydig cells in the testes to produce testosterone which ...

  9. Pharmacology of bicalutamide - Wikipedia

    en.wikipedia.org/wiki/Pharmacology_of_bicalutamide

    In accordance, clomifene, a selective estrogen receptor modulator with antiestrogenic activity, has been found to increase testosterone levels to as much as 250% of initial values in men with hypogonadism, [103] and a study of clomifene treatment in normal men observed increases in FSH and LH levels of 70–360% and 200–700%, respectively ...